These independent CME activities are supported by educational grants from Genentech, Inc



Clinical Context:
Gynecologic 
Cancers
  1. Course List
Chair
faculty image
Bradley J. Monk, MD, FACOG, FACS
  • Professor and Director
  • Division of Gynecologic Oncology
  • Department of Obstetrics and Gynecology
  • University of Arizona Cancer Center
  • Creighton University School of Medicine at Dignity Health St. Joseph’s Hospital and Medical Center
  • Phoenix, Arizona
  • Clinical Context: Gynecologic Cancers is designed to provide up-to-date information on current and emerging management strategies based on the most up-to-date evidence-based medicine and clinical trial results in gynecologic cancers. The curriculum includes case studies at the point of care and MedPage Today meeting coverage that will report on cutting-edge news as it breaks from the 2016 Annual Meeting on Women's Cancer SGO (Society of Gynecologic Oncology) and the 2016 ASCO (American Society of Clinical Oncology) Annual Meeting.
  • Describe the natural history of gynecologic cancers, the importance of early diagnosis of this condition, and recent advances in our understanding of pathophysiologic mechanisms that may serve as targets of therapy.
  • Evaluate criteria that have been developed to assess treatment response in gynecologic cancers, delineate how these criteria can be used to risk-stratify patients in clinical practice, and consider therapeutic treatment options to optimize treatment selection.
  • Target Audience

    This series of activities is designed for gynecologic oncologists, medical oncologists, radiation oncologists, gynecologists, internists, family practice physicians, primary care physicians, oncology nurses, nurse practitioners, physician assistants, and pharmacists involved in the screening and treatment of patients with gynecologic cancers.

     

    Activity Goal

    The goal of this program is to provide information and case studies at the point of care on current and emerging management strategies based on the most up-to-date evidence-based medicine and clinical trial results in gynecologic cancers.